Erin J. Mcallum
Parkville, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Therapeutic potential of iron modulating drugs in a mouse model of multiple system atrophy.
Journal: Neurobiology of disease
Published: May 23, 2021
Regional iron distribution and soluble ferroprotein profiles in the healthy human brain.
Journal: Progress in neurobiology
Published: July 30, 2019
A Review of ex vivo Elemental Mapping Methods to Directly Image Changes in the Homeostasis of Diffusible Ions (Na+, K+, Mg2 +, Ca2 +, Cl-) Within Brain Tissue.
Journal: Frontiers in neuroscience
Published: July 30, 2019
Metals in Alzheimer's and Parkinson's Disease: Relevance to Dementia with Lewy Bodies.
Journal: Journal of molecular neuroscience : MN
Published: June 15, 2016
Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SOD(G93A) mice co-expressing the Copper-Chaperone-for-SOD.
Journal: Neurobiology of disease
Published: November 03, 2015
Neonatal iron supplementation potentiates oxidative stress, energetic dysfunction and neurodegeneration in the R6/2 mouse model of Huntington's disease.
Journal: Redox biology
Published: January 27, 2015
Zn II(atsm) is protective in amyotrophic lateral sclerosis model mice via a copper delivery mechanism.
Journal: Neurobiology of disease
Published: November 05, 2014
Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: June 06, 2014
Therapeutic effects of CuII(atsm) in the SOD1-G37R mouse model of amyotrophic lateral sclerosis.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: August 20, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026